Bellon M, Baydoun H.H, Yao Y and Nicot C. HTLV-I Tax-dependent and independent events associated with Immortalization of Human Primary T-lymphocytes. Blood. 2010 Mar 25;115(12):2441-8. PMC2845900. Open access.
Bai XT, Baydoun HH, Nicot C. HTLV-I p30: A versatile protein modulating virus replication and pathogenesis. Mol Aspects Med. 2010 Jun 4. [Epub ahead of print]
Bai XT, Baydoun HH, Nicot C. HTLV-I p30: A versatile protein modulating virus replication and pathogenesis. Mol Aspects Med. 2010 Jun 4. [Epub ahead of print]
2009
Fukumoto R, Andresen V, Bialuk I, Cecchinato V, Walser JC, Valeri VW, Nauroth JM, Gessain A, Nicot C, Franchini G. In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood. 2009 Apr 16;113(16):3726-34. PMC2670790. Open access.
Baydoun HH, Bellon M, Nicot C. HTLV-I Yin and Yang:Rex and p30 master regulators of viral mRNA trafficking. AIDS Reviews. 2008 Oct-Dec; 10(4):195-204. PMC2666328. Open access.
Bellon M, Lepelletier Y, Hermine O, Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood. 2009 May 14;113(20): 4914-7. PMC2686141. Open access.
Taylor JM, Ghorbel S, Nicot C. Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30. BMC Genomics. 2009 Jul 14;10:311. PMC2723137. Open access.
Bellon M, Baydoun HH, Yao Y, Nicot C. HTLV-I Tax-dependent and independent events associated with Immortalization of Human Primary T-lymphocytes. Blood. (Accepted with revisions.)
Taylor JM, Brown M, Nejmeddine M, Kim KJ, Ratner L, Lairmore M, Nicot C. A novel role for IL2R-Jak signaling in retrovirus transmission. J Virol. 2009 Nov 83(22). Open access.
Taylor JM, Nicot C. HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis. 2008 Jun;13(6):733-47. Open access
Bellon M, Nicot C. Central role of PI3K in transcriptional activation of hTERT in HTLV-I infected cells. Blood. 2008 May 29. Open access
Bellon M, Nicot C. Regulation of telomerase and telomeres: human tumor viruses take control. J Natl Cancer Inst. 2008 Jan 16;100(2):98-108. Epub 2008 Jan 8.Open access.
Sinha-Datta U, Taylor JM, Brown M, Nicot C. Celecoxib disrupts the canonical apoptotic network in HTLV-I cells through activation of Bax and inhibition of PKB/Akt. Apoptosis. 2008 Jan;13(1):33-40.Open access.
2007
Bellon M, Nicot C. Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia. : Cancer Genomics Proteomics. 2007 Jan-Feb;4(1):21-5. Open access.
Datta A, Nicot C. Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells. Oncogene. 2007 Aug 20. Open access.
Lacoste V, Nicot C, Gessain A, Valensi F, Gabarre J, Matta H, Chaudhary PM, Mahieux R. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle. Br J Haematol. 2007 Aug;138(4):487-501. Open access
Sinha-Datta U, Datta A, Ghorbel S, Dodon MD, Nicot C. Human T-cell lymphotrophic virus type I rex and p30 interactions govern the switch between virus latency and replication. J Biol Chem. 2007 May 11;282(19):14608-15. Open access
Brown M, Bellon M, Nicot C. Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1. Blood. 2007 Feb 15;109(4):1653-9. Open access
Fukumoto R, Dundr M, Nicot C, Adams A, Valeri VW, Samelson LE, Franchini G. Inhibition of TCR Signal Transduction and Viral Expression by the Linker for Activation of T Cells-Interacting p12I Protein of HTLV-1. J Virol. 2007 Jun 20. Open access
2006
Ghorbel S, Sinha-Datta U, Dundr M, Brown M, Franchini G, Nicot C. Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J Biol Chem. 2006 Dec 1;281(48):37150-8. Open access
Bellon M, Datta A, Brown M, Pouliquen JF, Couppie P, Kazanji M, Nicot C. Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia. Int J Cancer. 2006 Nov 1;119(9):2090-7. Open access
Datta A, Sinha-Datta U, Dhillon NK, Buch S, Nicot C. The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti- inflammatory cytokines from human macrophages. J Biol Chem. 2006 Aug 18;281(33):23414-24.Open access
Datta A, Bellon M, Sinha-Datta U, Bazarbachi A, Lepelletier Y, Canioni D, Waldmann TA, Hermine O, Nicot C. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood. 2006 Aug 1;108(3):1021-9. Epub 2006 Mar 28. Open access
2005
Nicot C, Harrod RL, Ciminale V, Franchini G. Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene. 2005 Sep 5;24(39):6026-34. Open access
Nicot C. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol. 2005 Mar;78(3):232-9. Open access
2004
Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med. 2004 Feb;10(2):197-201. Open access
Sinha-Datta U, Horikawa I, Michishita E, Datta A, Sigler-Nicot JC, Brown M, Kazanji M, Barrett JC, Nicot C. Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood. 2004 Oct 15;104(8):2523-31. Open access